全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

血清残粒脂蛋白胆固醇是膝骨性关节炎进展的独立危险因素
Serum Remnant Lipoprotein Cholesterol Is an Independent Risk Factor for the Progression of Knee Osteoarthritis

DOI: 10.12677/ACM.2023.134918, PP. 6550-6560

Keywords: 骨性关节炎,残粒脂蛋白胆固醇,危险因素,血脂,甘油三酯
Osteoarthritis
, Remnant Lipoprotein Cholesterol, Risk Factor, Serum Lipids, Triglyceride

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:评估血脂各指标与膝骨性关节炎(OA)的关系,明确血清残粒脂蛋白胆固醇(RLP-C)与膝OA进展之间的相关性。方法:以2017年至2020年来我院就诊的OA患者为研究对象,建立OA研究队列,根据Kellgren-Lawrence分级将患者分为四个等级,收集身高、体重、病史等临床资料,测定血脂各指标,应用有序Logistic回归分析评估诱发OA进展的危险因素,应用线性趋势卡方检验评估血清RLP-C与膝OA是否线性相关。结果:共有2686名OA患者被纳入分析。随着OA分级增加,血清RLP-C水平逐渐升高,与I级OA患者相比,IV级OA患者的血清RLP-C水平增加了61.54%。甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)和RLP-C均是OA进展的危险因素,而高密度脂蛋白胆固醇(HDL-C)却是阻止OA进展的保护因素。在男性人群中,与正常水平者相比,RLP-C水平升高者OA进展风险增加约3.41倍,在女性人群,这个风险增加约1.71倍,校正混杂因素后,结果仍具有统计学意义。无论在总人群,还是男性或者女性人群,OA分级与血清RLP-C水平之间呈显著线性正相关。结论:血清RLP-C水平升高是OA进展的重要独立危险因素,随着血清RLP-C水平升高,OA严重程度呈线性增加。
Objective: This study aims to assess the association between serum lipid parameters and osteoar-thritis (OA) and elucidate the correlation between remnant lipoprotein cholesterol (RLP-C) and the knee OA progression. Methods: An OA cohort was established which included all the OA patients treated in Shandong Provincial Hospital Affiliated to Shandong First Medical University from 2017 to 2020. OA was divided into four grades based on Kellgren-Lawrence classification. Height, weight, medical history, and other clinical data were collected. Serum lipid parameters were determined. Ordered logistic regression analysis was used to evaluate the risk factors of OA progression. Linear trend X2 test was used to analyze the linear trend between the serum RLP-C level and the classifica-tion of OA. Results: A total of 2686 individuals were included in the final analysis. The serum RLP-C level increased with the elevation of OA classification. Compared to patients with grade I OA, the serum RLP-C level in patients with grade IV OA was 61.54% higher. Triglyceride (TG), total choles-terol (TC), and low density lipoprotein cholesterol (LDL-C) were all risk factors for the progression of OA, while high density lipoprotein cholesterol (HDL-C) was the protective factor. Compared to indi-viduals with normal RLP-C level, the risk for OA progression increased approximately 3.41-fold among subjects with high RLP-C in men and approximately 1.7-fold in women. After adjustment for confounding factors, the results were still statistically significant. A significant positive linear corre-lation between OA grade and serum RLP-C level was identified in the total population, men or women. Conclusions: High RLP-C level is an independent risk factor for the progression of OA. OA severity increased linearly with the elevation of serum RLP-C levels.

References

[1]  Abramoff, B. and Caldera, F.E. (2020) Osteoarthritis: Pathology, Diagnosis, and Treatment Options. Medical Clinics of North America, 104, 293-311.
https://doi.org/10.1016/j.mcna.2019.10.007
[2]  廖德发. 我国骨性关节炎流行病学调查现状[J]. 微创医学, 2017, 12(4): 521-524.
[3]  Masuko, K., Murata, M., Suematsu, N., Okamoto, K. and Kato, T.J.C. (2009) A Metabolic Aspect of Osteoarthritis: Lipid as a Possible Contributor to the Pathogenesis of Cartilage Degradation. Clinical Experimental Rheumatology, 27, 347-353.
[4]  Varbo, A. and Nordestgaard, B.G. (2017) Rem-nant Lipoproteins. Current Opinion in Lipidology, 28, 300-307.
https://doi.org/10.1097/MOL.0000000000000429
[5]  Wang, H., Bai, J., He, B., Hu, X. and Liu, D. (2016) Oste-oarthritis and the Risk of Cardiovascular Disease: A Meta-Analysis of Observational Studies. Scientific Reports, 6, Arti-cle No. 39672.
https://doi.org/10.1038/srep39672
[6]  Tchetina, E.V., Markova, G.A. and Sharapova, E.P. (2020) Insulin Resistance in Osteoarthritis: Similar Mechanisms to Type 2 Diabetes Mellitus. Journal of Nutrition and Metabo-lism, 2020, Article ID: 4143802.
https://doi.org/10.1155/2020/4143802
[7]  中华医学会骨科学分会关节外科学组, 中国医师协会骨科医师分会骨关节炎学组, 国家老年疾病临床医学研究中心. 中国骨关节炎诊疗指南(2021年版) [J]. 中华骨科杂志, 2021, 41(18): 24.
[8]  Joint Committee for Guideline Revision (2019) 2018 Chinese Guidelines for Prevention and Treatment of Hypertension—A Report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hyper-tension. Journal of Geriatric Cardiology, 16, 182-241.
[9]  Xu, C., Zhou, G., Zhao, M., Zhang, X., Fang, L., Guan, Q., et al. (2021) Bidirectional Temporal Relationship between Obesity and Hyperinsulinemia: Longitudinal Observation from a Chinese Cohort. BMJ Open Diabetes Research & Care, 9, e002059.
https://doi.org/10.1136/bmjdrc-2020-002059
[10]  Kellgren, J.H. and Lawrence, J.S. (1957) Radiological Assess-ment of Osteoarthrosis. Annals of Rheumatic Diseases, 16, 494-502.
https://doi.org/10.1136/ard.16.4.494
[11]  Vina, E.R. and Kwoh, C.K. (2018) Epidemiology of Osteoarthritis: Liter-ature Update. Current Opinion in Rheumatology, 30, 160-167.
https://doi.org/10.1097/BOR.0000000000000479
[12]  辛丽维. 中国膝关节骨关节炎流行病学调查现状[J]. 双足与保健, 2018, 27(20): 73-74.
[13]  Yoshimura, N. (2018) Cartilage/Chondrocyte Research and Osteoarthritis. Epide-miology of Osteoarthritis in Japan. Clinical Calcium, 28, 761-766.
[14]  Woodell-May, J.E. and Sommerfeld, S.D. (2020) Role of Inflammation and the Immune System in the Progression of Osteoarthritis. Journal of Orthopaedic Research, 38, 253-257.
https://doi.org/10.1002/jor.24457
[15]  O’Neill, T.W., McCabe, P.S. and McBeth, J. (2018) Update on the Epidemiology, Risk Factors and Disease Outcomes of Osteoarthritis. Best Practice & Research: Clinical Rheumatology, 32, 312-326.
https://doi.org/10.1016/j.berh.2018.10.007
[16]  Courties, A., Berenbaum, F. and Sellam, J. (2019) The Phenotypic Approach to Osteoarthritis: A Look at Metabolic Syndrome-Associated Osteoarthritis. Joint Bone Spine, 86, 725-730.
https://doi.org/10.1016/j.jbspin.2018.12.005
[17]  Ran, L., Chen, Q., Zhang, J., Tu, X., Tan, X. and Zhang, Y. (2021) The Multimorbidity of Hypertension and Osteoarthritis and Relation with Sleep Quality and Hyperlipe-mia/Hyperglycemia in China’s Rural Population. Scientific Reports, 11, Article No. 17046.
https://doi.org/10.1038/s41598-021-96523-0
[18]  Sanchez-Santos, M.T., Judge, A., Gulati, M., et al. (2019) As-sociation of Metabolic Syndrome with Knee and Hand Osteoarthritis: A Community-Based Study of Women. Seminars in Arthritis and Rheumatism, 48, 791-798.
https://doi.org/10.1016/j.semarthrit.2018.07.007
[19]  Mishra, R., Singh, A., Chandra, V., et al. (2012) A Compara-tive Analysis of Serological Parameters and Oxidative Stress in Osteoarthritis and Rheumatoid Arthritis. Rheumatology International, 32, 2377-2382.
https://doi.org/10.1007/s00296-011-1964-1
[20]  Ioan-Facsinay, A. and Kloppenburg, M. (2018) Bioactive Lipids in Osteoarthritis: Risk or Benefit? Current Opinion in Rheumatology, 30, 108-113.
https://doi.org/10.1097/BOR.0000000000000463
[21]  Tada, H., Nohara, A., Inazu, A., Mabuchi, H. and Ka-washiri, M.A. (2019) Remnant Lipoproteins and Atherosclerotic Cardiovascular Disease. Clinica Chimica Acta, 490, 1-5.
https://doi.org/10.1016/j.cca.2018.12.014
[22]  Sandesara, P.B., Virani, S.S., Fazio, S. and Shapiro, M.D. (2019) The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk. Endocrine Reviews, 40, 537-557.
https://doi.org/10.1210/er.2018-00184
[23]  Shen, J., Abu-Amer, Y., O’Keefe, R.J. and McAlinden, A. (2017) In-flammation and Epigenetic Regulation in Osteoarthritis. Connective Tissue Research, 58, 49-63.
https://doi.org/10.1080/03008207.2016.1208655
[24]  Romero, J.B., Schreiber, A., Von Hochstetter, A.R., Wag-enhauser, F.J., Michel, B. and Theiler, R. (1996) Hyperostotic and Destructive Osteoarthritis in a Patient with Vitamin A Intoxication Syndrome: A Case Report. Bulletin (Hospital for Joint Diseases (New York, NY)), 54, 169-174.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133